Abstract
Ganoderic acid 3‐hydroxy‐lanosta‐8,24‐dien‐26‐oic acid (GA‐HLDOA), an antitumor triterpenoid from the traditional Chinese medicinal higher fungus Ganoderma lucidum, is considered as a key precursor for biosynthesizing other ganoderic acids (GAs) with superior antitumor activities. Our previous study identified CYP5150L8 from G. lucidum as a lanosterol oxidase, and achieved heterologous biosynthesis of GA‐HLDOA in Saccharomyces cerevisiae. However, low production of GA‐HLDOA in either G. lucidum or heterologous host hindered its further investigation and application. In this study, we constructed a dual tunable system for balancing the expression of CYP5150L8 and a Ganoderma P450 reductase iGLCPR, and performed a comprehensive optimization of CYP5150L8 expression, iGLCPR expression, and glycerol usage. Then, we investigated the fermentation behavior of the best strain in optimized condition in flask and achieved 154.45 mg/L GA‐HLDOA production, which was 10.7‐fold higher compared with previous report. This study may facilitate the wide‐spread application of GA‐HLDOA and the discovery of unknown cytochrome P450s in downstream GAs biosynthesis.
Funding Information
  • National Natural Science Foundation of China (31600071)
  • Natural Science Foundation of Shanghai Municipality (17ZR1448900, 18ZR1420300)

This publication has 47 references indexed in Scilit: